Madrigal Pharma Files Definitive Proxy Materials
Ticker: MDGL · Form: DEFA14A · Filed: Apr 28, 2026 · CIK: 0001157601
| Field | Detail |
|---|---|
| Company | Madrigal Pharmaceuticals, Inc. (MDGL) |
| Form Type | DEFA14A |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-governance
Related Tickers: MDGL
TL;DR
Madrigal Pharma (MDGL) filed proxy docs 4/28. Expect shareholder votes soon.
AI Summary
Madrigal Pharmaceuticals, Inc. filed a Definitive Additional Materials (DEFA14A) on April 28, 2026. The filing, with accession number 0001104659-26-050349, contains proxy soliciting materials. The company's mailing and business address is 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.
Why It Matters
This filing indicates that Madrigal Pharmaceuticals is actively engaged in soliciting shareholder votes or providing important information related to corporate governance or upcoming decisions.
Risk Assessment
Risk Level: low — This is a routine filing for proxy materials and does not inherently indicate significant new risks.
Key Players & Entities
- MADRIGAL PHARMACEUTICALS, INC. (company) — Filer
- 0001104659-26-050349 (filing_id) — Accession Number
- 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 (address) — Mailing and Business Address
FAQ
What type of filing is this DEFA14A for Madrigal Pharmaceuticals?
This is a Definitive Additional Materials filing, used for proxy soliciting materials.
When was this DEFA14A filing accepted by the SEC?
The filing was accepted on April 28, 2026.
What is the CIK number for Madrigal Pharmaceuticals?
The CIK number for Madrigal Pharmaceuticals is 0001157601.
What is the primary business of Madrigal Pharmaceuticals according to the SIC code?
According to the SIC code 2834, the primary business is Pharmaceutical Preparations.
Where is Madrigal Pharmaceuticals located?
Madrigal Pharmaceuticals' mailing and business address is 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 28, 2026 regarding MADRIGAL PHARMACEUTICALS, INC. (MDGL).